Real-time localization, targeting, and confirmation of tool-in-lesion

96.7%

Diagnostic yield
ATS strict definition

Faster cases and
simplified workflow

25%

Higher utilization than other
RAB platforms

Scale without added costs, infrastructure, or radiation dose

Up To 10x

Less radiation
(DT vs CBCT)